Immune Checkpoint Inhibitors and Inflammatory Myopathies: Data from the US Food and Drug Administration Adverse Event Reporting System

被引：0
|
作者：
Pundole, Xerxes [1 ]
Shah, Mohsin [1 ]
Abdel-Wahab, Noha [1 ]
Suarez-Almazor, Maria [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Sect Rheumatol & Clin Immunol, Dept Gen Internal Med, Houston, TX 77030 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
850
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the US Food and Drug Administration Adverse Event Reporting System
    Raschi, Emanuel
    Antonazzo, Ippazio Cosimo
    La Placa, Michelangelo
    Ardizzoni, Andrea
    Poluzzi, Elisabetta
    De Ponti, Fabrizio
    ONCOLOGIST, 2019, 24 (11): : E1228 - E1231
  • [2] RHEUMATIC AND MUSCULOSKELETAL ADVERSE EVENTS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS: DATA MINING OF THE US FOOD AND DRUG ADMINISTRATION ADVERSE EVENT REPORTING SYSTEM
    Pundole, X.
    Sarangdhar, M.
    Suarez-Almazor, M. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 147 - 148
  • [3] SKELETAL ADVERSE EVENTS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS: EMERGING TRENDS FROM THE US FOOD AND DRUG ADMINISTRATION ADVERSE EVENT REPORTING SYSTEM
    Pundole, X.
    Sarangdhar, M.
    Suarez-Almazor, M. E.
    VALUE IN HEALTH, 2019, 22 : S486 - S486
  • [4] Hepatotoxicity Associated with Immune Checkpoint Inhibitors in Clinical Practice: A Study Leveraging Data from the US Food and Drug Administration's Adverse Event Reporting System
    Yang, Hui
    Wang, Haozhou
    Zhou, Xiaoguang
    Zhang, Xiaodong
    CLINICAL THERAPEUTICS, 2023, 45 (02) : 151 - 159
  • [5] Common Immune-Related Adverse Events of Immune Checkpoint Inhibitors in the Gastrointestinal System: A Study Based on the US Food and Drug Administration Adverse Event Reporting System
    Bai, Xiaoyin
    Jiang, Shiyu
    Zhou, Yangzhong
    Zhen, Hongnan
    Ji, Junyi
    Li, Yi
    Ruan, Gechong
    Yang, Yang
    Shen, Kaini
    Wang, Luo
    Li, Guanqiao
    Yang, Hong
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [6] Hepatic failure associated with immune checkpoint inhibitors: An analysis of the Food and Drug Administration Adverse Event Reporting System database
    Xu, Ye
    Yan, Cilin
    Zhao, Ying
    Li, Dandan
    Guo, Mingxing
    Cui, Xiangli
    CANCER MEDICINE, 2023, 12 (08): : 9167 - 9174
  • [7] Erythema multiforme associated with the immune checkpoint inhibitors: A disproportionality analysis using the Food and Drug Administration Adverse Event Reporting System
    Godfrey, Hannah
    Leibovit-Reiben, Zachary
    Jedlowski, Patrick
    Thiede, Rebecca
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (06) : 1233 - 1234
  • [8] Immune-related adverse events in older adults receiving immune checkpoint inhibitors: a comprehensive analysis of the Food and Drug Administration Adverse Event Reporting System
    Esen, Bugra Han
    Bektas, Sevval Nur
    Topcu, Umur
    Koylue, Bahadir
    Kuvvet, Fadime Buket Bayram
    Bahat, Gulistan
    Selcukbiricik, Fatih
    AGE AND AGEING, 2025, 54 (01)
  • [9] Dipeptidyl Peptidase 4 Inhibitors and Gallbladder or Biliary Diseases: Data From the US Food and Drug Administration Adverse Event Reporting System
    He, Liyun
    Wang, Jialu
    Li, Ziyi
    Li, Yuxiu
    Zhang, Huabing
    DIABETES CARE, 2023, 46 (02) : E72 - E73
  • [10] Thromboembolic events associated with immune checkpoint inhibitors: A real-world study of data from the food and drug administration adverse event reporting system (FAERS) database
    Li, Hao
    Sun, Ximu
    Sun, Dan
    Zhao, Jin
    Xu, Zhouming
    Zhao, Peng
    Ma, Zhuo
    Zhang, Yuhui
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 98
12345